Previous 10 | Next 10 |
home / stock / nmlsf / nmlsf news
Nova Mentis Announces Closing of Non-Brokered Financing Canada NewsWire VANCOUVER, BC , March 15, 2022 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in fi...
Nova Mentis Study Confirms Oral Microdose Psilocybin Treatment of Autism Canada NewsWire VANCOUVER, BC , Feb. 16, 2022 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and glo...
/R E P E A T - Nova Mentis and KGK Science Form Tactical Partnership/ Canada NewsWire The Companies Plan to Jointly Submit a Psilocybin Clinical Trial Application to Health Canada VANCOUVER, BC , Jan. 27, 2022 /CNW/ - Nova Mentis Life Science Co...
Nova Mentis and KGK Science Form Tactical Partnership Canada NewsWire The Companies Plan to Jointly Submit a Psilocybin Clinical Trial Application to Health Canada VANCOUVER, BC , Jan. 27, 2022 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA...
VANCOUVER, British Columbia, Jan. 27, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), an evidence-based healthcare company focused on innovative clinical solutions, artificial i...
Nova Mentis Provides Corporate Update - 2022 Planned Catalysts Canada NewsWire VANCOUVER, BC , Jan. 12, 2022 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader...
Nova Mentis Welcomes New CFO Rebecca Hudson Canada NewsWire VANCOUVER, BC , Dec. 31, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psil...
Nova Mentis Files Genetic Neuroinflammatory Disease Patent Canada NewsWire Messenger RNA Diagnostic/Treatment Paradigm VANCOUVER, BC , Nov. 9, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Com...
Nova Mentis to Present at the Wonderland: Miami Psychedelic Conference Canada NewsWire VANCOUVER, BC , Nov. 4, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global...
U.S. FDA Approves Nova Mentis Orphan Drug Application Canada NewsWire Psilocybin Fragile X Syndrome Treatment VANCOUVER, BC , Nov. 2, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"...
News, Short Squeeze, Breakout and More Instantly...
Nova Mentis Life Science Corp Company Name:
NMLSF Stock Symbol:
OTCMKTS Market:
Nova Mentis Life Science Corp Website:
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company") announces the appointment of Steve Loutskou to the Company's Board of Directors, effective February 23, 2024. Mr. Loutskou, a seas...
Vancouver, British Columbia--(Newsfile Corp. - November 3, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroin...
Vancouver, British Columbia--(Newsfile Corp. - August 30, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinf...